U.S. Physical Therapy, Inc. (USPH) — Fair Value Analysis
Base-case fair value (P50): $79.80 · Current price: $81.24 · Verdict: Fairly Valued
The Verdict on USPH
US PHYSICAL THERAPY INC (USPH) appears Fairly Valued based on our Monte Carlo simulations, with its current market price closely aligning with the computed median fair value. The analysis indicates that USPH's $81.24 trades very near its P50 fair value of $79.80. This suggests the market is largely pricing in the company's fundamentals as determined by our forward-looking models, with a marginal upside potential of -1.8% from the current valuation. Investors seeking significant discounts or premiums might find USPH's current positioning less compelling, as the stock is not presenting a clear overvaluation or undervaluation signal at this time.
How USPH stacks up against peers
When evaluating USPH within its operating environment, our quality tier assessment places the company at an average level regarding its operational and financial health compared to sector peers. This average rating reflects a balanced profile, suggesting that USPH is neither a standout performer nor a laggard in terms of its underlying business strength. While the current price of $81.24 is consistent with an average quality tier company trading around its fair value, investors should consider that an average tier company might have more limited catalysts for substantial outperformance compared to higher-quality firms. The -1.8% indicates a relatively contained deviation from the median fair value $79.80.
What this means for investors
For investors considering USPH, the Fairly Valued verdict and the -1.8% indicate that the stock is currently priced efficiently by the market. The P50 fair value of $79.80 provides a central estimate, and the proximity of $81.24 to this value suggests that the market has assimilated known information effectively. While there isn't a strong signal for immediate, significant outperformance or undervaluation, the average quality tier implies a stable, if not exceptional, operational foundation. To understand the full spectrum of potential outcomes for USPH, including the bear and bull case scenarios, sign up for a free FairCurve account. This will allow you to see the complete probability distribution and track USPH's fair value as new fundamentals are released.
Frequently Asked Questions
Is USPH overvalued or undervalued right now?
Based on our Monte Carlo simulations, USPH is currently considered Fairly Valued, with its current price of $81.24 trading very close to its P50 fair value of $79.80.
What is the bear case and bull case for USPH?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices for USPH, along with the probability of upside, is available when you sign up for a free FairCurve account. We do not publish specific price targets here.
How does FairCurve calculate USPH's fair value?
FairCurve calculates USPH's fair value using Monte Carlo simulations, which run thousands of forward-looking financial scenarios to derive a comprehensive probability distribution of potential valuations.
How can I track USPH's fair value as it changes?
You can add USPH to a free FairCurve watchlist to receive daily fair-value updates. FairCurve will instantly re-evaluate USPH's fair value whenever new earnings data or significant fundamental news is released.